Clinical Trials in Pittsburgh

Showing 3521-3540 of 21,047 trials

QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing

NCT03434392

Quantitative Sensory Testing (QST) is a novel investigative technique used in other pain conditions to evaluate patterns of chronic pain, and in this study will be used to elucidate pain patterns in patients with Chronic Pancreatitis (CP). QST uses a specific series of standardized stimulations to map the pain system. QST has the potential to change and improve the treatment paradigm for patients with CP and may eventually be able to predict response to invasive CP therapies.

Chronic PancreatitisChronic Pain

Anna Evans Phillips500 participantsStarted Oct 2017

Baltimore, Maryland, United States • Pittsburgh, Pennsylvania, United States

Active Not RecruitingNA< 1 mile

SyncAV Post-Market Trial

NCT04100148

The SyncAV Post-Market Trial is a prospective, randomized, multi-center trial performed to determine if cardiac resynchronization therapy (CRT) devices programmed with SyncAV ON improve long-term CRT response compared to devices programmed with conventional CRT through evaluation of changes in left ventricular (LV) reverse remodeling.

Congestive Heart Failure

Abbott Medical Devices1,686 participantsStarted Oct 2019

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +101 more locations

QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing

SyncAV Post-Market Trial

Find Trials by Condition in Pittsburgh

Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder

Tongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Head and Neck Cancer

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers

Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

Blue Light Cystoscopy With Cysview® Registry

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)

Multisite Virtual Reality Intervention for Speech Anxiety

Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)

Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations

A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement

Long-Term Follow-Up (LTFU) for Gene Therapy of Leukocyte Adhesion Deficiency-I (LAD-I)

An Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCID